• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

26,26,26,27,27,27-六氘代-1,25-二羟基维生素 D3(1,25D-d6)作为乳腺癌细胞系化疗的辅助剂。

26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines.

机构信息

Department of Physiology-CIMUS, Endocrine Oncology Laboratories (P1L3), Avda. Barcelona s/n, Campus Vida-University of Santiago de Compostela, Santiago de Compostela 15782, Spain.

出版信息

Cancers (Basel). 2013 Dec 27;6(1):67-78. doi: 10.3390/cancers6010067.

DOI:10.3390/cancers6010067
PMID:24378752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3980618/
Abstract

It has been demonstrated that 1,25-dihydroxyvitamin D3 (1,25D) and some of its analogues have antitumor activity. 1,25D labeled with deuterium (26,26,26,27,27,27-hexadeuterated 1a,25-dihydroxyvitamin D3, or 1,25D-d6) is commonly used as internal standard for 1,25D liquid chromatography-mass spectrometry (LC-MS) quantification. In the present study using human breast cancer cell lines, the biological activity of 1,25D-d6 administered alone and in combination with two commonly used antineoplastic agents, 5-fluorouracil and etoposide, was evaluated. Using an MTT assay, flow cytometry, and western blots, our data demonstrated that 1,25D-d6 has effects similar to the natural hormone on cell proliferation, cell cycle, and apoptosis. Furthermore, the combination of 1,25D-d6 and etoposide enhances the antitumoral effects of both compounds. Interestingly, the antitumoral effect is higher in the more aggressive MDA-MB-231 breast cancer cell line. Our data indicate that 1,25D-d6 administered alone or in combination with chemotherapy could be a good experimental method for accurately quantifying active 1,25D levels in cultures or in biological fluids, on both in vitro breast cancer cell lines and in vivo animal experimental models.

摘要

已经证实 1,25-二羟维生素 D3(1,25D)及其类似物具有抗肿瘤活性。氘标记的 1,25D(26,26,26,27,27,27-六氘代 1a,25-二羟维生素 D3,或 1,25D-d6)通常用作 1,25D 液相色谱-质谱(LC-MS)定量分析的内标。在本研究中,使用人乳腺癌细胞系,评估了单独给予 1,25D-d6 以及与两种常用抗肿瘤药物 5-氟尿嘧啶和依托泊苷联合应用的生物学活性。通过 MTT 测定、流式细胞术和 Western blot,我们的数据表明 1,25D-d6 对细胞增殖、细胞周期和凋亡具有与天然激素相似的作用。此外,1,25D-d6 和依托泊苷的联合使用增强了这两种化合物的抗肿瘤作用。有趣的是,这种抗肿瘤作用在侵袭性更强的 MDA-MB-231 乳腺癌细胞系中更高。我们的数据表明,单独给予 1,25D-d6 或与化疗联合使用可能是一种很好的实验方法,可用于准确定量培养物或生物流体中活性 1,25D 水平,包括体外乳腺癌细胞系和体内动物实验模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/472929f439b1/cancers-06-00067-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/358154976d01/cancers-06-00067-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/b11115eed344/cancers-06-00067-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/125a1042608e/cancers-06-00067-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/f96638a8a68b/cancers-06-00067-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/472929f439b1/cancers-06-00067-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/358154976d01/cancers-06-00067-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/b11115eed344/cancers-06-00067-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/125a1042608e/cancers-06-00067-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/f96638a8a68b/cancers-06-00067-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bc/3980618/472929f439b1/cancers-06-00067-g005.jpg

相似文献

1
26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines.26,26,26,27,27,27-六氘代-1,25-二羟基维生素 D3(1,25D-d6)作为乳腺癌细胞系化疗的辅助剂。
Cancers (Basel). 2013 Dec 27;6(1):67-78. doi: 10.3390/cancers6010067.
2
Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.野生型和维生素D3受体基因敲除小鼠乳腺肿瘤细胞系的特征分析
Mol Cell Endocrinol. 2003 Feb 28;200(1-2):67-80. doi: 10.1016/s0303-7207(02)00416-1.
3
Identification of vitamin D target genes in human breast cancer tissue.人类乳腺癌组织中维生素D靶基因的鉴定
J Steroid Biochem Mol Biol. 2016 Nov;164:90-97. doi: 10.1016/j.jsbmb.2015.10.012. Epub 2015 Oct 17.
4
Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.蛋白激酶 CK2 的抑制可降低 Cyp24a1 的表达,并增强人前列腺癌细胞中 1,25-二羟维生素 D(3)的抗肿瘤活性。
Cancer Res. 2013 Apr 1;73(7):2289-97. doi: 10.1158/0008-5472.CAN-12-4119. Epub 2013 Jan 28.
5
Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.鼠尾草酸可增强1α,25-二羟基维生素D3在白血病细胞中的抗氧化和促分化作用,但不会促使细胞内钙的基础水平升高。
Cancer Res. 2003 Mar 15;63(6):1325-32.
6
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system.依钙醇,1,25D3 的类似物,在鳞状细胞癌模型系统中通过诱导细胞凋亡显示出增强的抗肿瘤活性。
Cell Cycle. 2013 Mar 1;12(5):743-52. doi: 10.4161/cc.23846. Epub 2013 Feb 6.
7
Modeling vitamin D actions in triple negative/basal-like breast cancer.三阴性/基底样乳腺癌中维生素 D 作用的建模。
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:65-73. doi: 10.1016/j.jsbmb.2013.10.022. Epub 2013 Nov 14.
8
1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest.1α,25-二羟维生素 D3 通过视网膜母细胞瘤蛋白(Rb)非依赖性 G1 期阻滞抑制 C4-2 前列腺癌细胞生长。
Prostate. 2011 Jan 1;71(1):98-110. doi: 10.1002/pros.21226.
9
Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D on the mature osteoblast cell line MLO-A5.外源性和内源性1,25-二羟基维生素D对成熟成骨细胞系MLO-A5生物学效应的比较。
J Steroid Biochem Mol Biol. 2016 Nov;164:374-378. doi: 10.1016/j.jsbmb.2016.03.004. Epub 2016 Mar 4.
10
IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.白细胞介素-6损害维生素D3在三阴性乳腺癌上皮-间质转化调节中的活性。
Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2267-2273. doi: 10.31557/APJCP.2019.20.8.2267.

本文引用的文献

1
Diastereotopic and deuterium effects in gemini.双子星中的立体异构和氘效应。
J Med Chem. 2013 May 23;56(10):3878-88. doi: 10.1021/jm400032t. Epub 2013 May 9.
2
Analytical measurement of serum 25-OH-vitamin D₃, 25-OH-vitamin D₂ and their C3-epimers by LC-MS/MS in infant and pediatric specimens.采用 LC-MS/MS 法分析婴幼儿血清 25-羟基维生素 D₃、25-羟基维生素 D₂及其 C3-差向异构体
Clin Biochem. 2013 Sep;46(13-14):1264-71. doi: 10.1016/j.clinbiochem.2012.11.030. Epub 2012 Dec 23.
3
Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum.
同位素稀释超高效液相色谱-串联质谱法同时测定人血清中 25-羟维生素 D2、25-羟维生素 D3 和 3-差向-25-羟维生素 D3
Clin Chim Acta. 2011 Aug 17;412(17-18):1594-9. doi: 10.1016/j.cca.2011.05.010. Epub 2011 May 13.
4
Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis.pit-1 转录因子在人乳腺癌细胞中的去调控促进肿瘤生长和转移。
J Clin Invest. 2010 Dec;120(12):4289-302. doi: 10.1172/JCI42015. Epub 2010 Nov 8.
5
Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.维生素 D 信号转导和代谢途径在乳腺癌进展中的改变:VDR、CYP27B1 和 CYP24A1 在良性和恶性乳腺病变中的表达研究。
BMC Cancer. 2010 Sep 11;10:483. doi: 10.1186/1471-2407-10-483.
6
Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.维生素 D:作为癌症预防和治疗药物持续开发的考虑因素。
Cancer J. 2010 Jan-Feb;16(1):1-9. doi: 10.1097/PPO.0b013e3181c51ee6.
7
Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage.细胞对依托泊苷的反应:尽管细胞周期阻滞和 DNA 损伤修复,但仍发生细胞死亡。
Apoptosis. 2010 Feb;15(2):162-72. doi: 10.1007/s10495-009-0440-9.
8
Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity.
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3131-8. doi: 10.1158/1535-7163.MCT-07-0427.
9
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.癌症中的维生素D信号通路:抗癌治疗的潜力
Nat Rev Cancer. 2007 Sep;7(9):684-700. doi: 10.1038/nrc2196.
10
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors.一项关于静脉注射骨化三醇联合口服吉非替尼用于晚期实体瘤患者的I期药代动力学和药效学研究。
Clin Cancer Res. 2007 Feb 15;13(4):1216-23. doi: 10.1158/1078-0432.CCR-06-1165.